Last Updated: June 22, 2026

BENZTROPINE Drug Patent Profile

Name: BENZTROPINE Drug Patent, Exclusivity, and Generic Launch Dataset
Creator: DrugPatentWatch
License: https://www.drugpatentwatch.com/terms.php

✉ Email this page to a colleague

« Back to Dashboard

Which patents cover Benztropine, and what generic alternatives are available?

Benztropine is a drug marketed by Fresenius Kabi Usa, Hikma, Hikma Farmaceutica, Luitpold, Navinta Llc, Aiping Pharm Inc, Chartwell Rx, Epic Pharma Llc, Invagen Pharms, Lannett Co Inc, Leading, Nuvo Pharm, Oxford Pharms, Ph Health, Pliva, Quagen, Quantum Pharmics, and Usl Pharma. and is included in twenty-eight NDAs.

The generic ingredient in BENZTROPINE is benztropine mesylate. There are seven drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the benztropine mesylate profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Benztropine

A generic version of BENZTROPINE was approved as benztropine mesylate by PLIVA on August 10^th, 1988.

Start Trial

AI Deep Research

Questions you can ask:

What is the 5 year forecast for BENZTROPINE?
What are the global sales for BENZTROPINE?
What is Average Wholesale Price for BENZTROPINE?

Summary for BENZTROPINE

US Patents:	0
Applicants:	18
NDAs:	28
Drug Prices:	Drug price information for BENZTROPINE
DailyMed Link:	BENZTROPINE at DailyMed

Drug patent expirations by year for BENZTROPINE

US Patents and Regulatory Information for BENZTROPINE

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Quantum Pharmics	BENZTROPINE MESYLATE	benztropine mesylate	TABLET;ORAL	088511-001	Jan 31, 1984		DISCN	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Ph Health	BENZTROPINE MESYLATE	benztropine mesylate	TABLET;ORAL	040715-003	Aug 27, 2007	AA	RX	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Oxford Pharms	BENZTROPINE MESYLATE	benztropine mesylate	TABLET;ORAL	040706-003	Feb 14, 2008		DISCN	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.